Summary & Overview
CPT 0369T: Duodenal Mucosal Resurfacing, Endoscopic
CPT code 0369T defines endoscopic duodenal mucosal resurfacing, an interventional endoscopic technique that ablates and remodels duodenal mucosa. The procedure is emerging in gastroenterology as a potential treatment for select duodenal and metabolic conditions. Nationally, adoption of this procedure affects endoscopy service utilization, facility preparedness, and payer coverage decisions for novel endoscopic therapies.
Key payers covered in this analysis include Aetna, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines which payers have explicit coverage language, common clinical indications associated with the procedure, and how this code relates to standard diagnostic upper endoscopy services. Readers will find benchmarks for billing and utilization patterns, policy and coverage considerations relevant to endoscopic therapeutic codes, and clinical context linking duodenal mucosal resurfacing to gastrointestinal disease indications.
This summary provides a concise resource for billing managers, gastroenterology groups, and compliance staff to understand the role of CPT code 0369T in clinical practice and payer policy. Data not available in the input is noted where applicable in detailed sections.
Billing Code Overview
CPT code 0369T describes duodenal mucosal resurfacing, endoscopic, a therapeutic endoscopic procedure that ablates and remodels the duodenal mucosa. The service type is an endoscopic therapeutic procedure typically performed in an endoscopy suite or ambulatory surgical center and may be delivered with monitored anesthesia care or sedation as part of routine endoscopic services.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45–65-year-old adult with type 2 diabetes mellitus and persistent upper abdominal symptoms or metabolic indications seeking endoscopic treatment to improve duodenal mucosal pathology and glycemic control. The patient has failed or not tolerated optimized medical therapy (diet, oral hypoglycemics) and is referred by a gastroenterologist or hepatologist for 0369T duodenal mucosal resurfacing performed under moderate sedation or general anesthesia in an endoscopy suite. Pre-procedure workflow includes history and medication review, informed consent, fasting, and assessment for anticoagulation management. The procedure is performed during an esophagogastroduodenoscopy (EGD) session: an endoscope is advanced to the duodenum, a dedicated catheter is used to lift and hydrothermally ablate the superficial duodenal mucosa circumferentially or segmentally, and post-ablation inspection is completed. Typical post-procedure workflow includes recovery monitoring, discharge instructions addressing diet progression and signs of complication (bleeding, perforation), and follow-up visits to assess symptom improvement and glycemic markers. Documentation should include indication, informed consent, sedation type, description of mucosal resurfacing technique, treated duodenal segments, immediate findings, and any complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |